Can genes predict ovarian cancer risk?
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at whether a score based on your genes can predict the risk of epithelial ovarian cancer. It compares women newly diagnosed with this cancer to women who have never had it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with a new diagnosis of epithelial ovarian or fallopian tube cancer.
- Or you are a woman who has never been diagnosed with ovarian cancer.
- You must not have any other active cancer besides ovarian cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic changes in ovarian cancer to find possible targeted treatments. It may help you if you have certain types of ovarian cancer and are seeking more personalized care.
This study looks at how medical images relate to genetic patterns in high-grade serous ovarian cancer. It may help find better ways to diagnose and treat this specific type of ovarian cancer.
This study compares a new tool that estimates your personal risk of ovarian cancer with the usual approach. It aims to see if using this tool helps people make more informed decisions about screening and prevention.
This study is testing whether a simple blood test can predict the risk of ovarian cancer coming back after treatment. It might help doctors decide who needs more aggressive therapy.
This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.
This study follows women who carry gene mutations that increase ovarian cancer risk to understand how preventive surgery affects their health, quality of life, and peace of mind. Researchers will track your outcomes over 3 years to help inform future treatment decisions for others at similar risk.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.